CXCL13 predicts long term radiographic status in early rheumatoid arthritis.

Stinne Ravn GreisenClara MikkelsenMerete Lund HetlandMikkel ØstergaardKim Hørslev-PetersenPeter JunkerKristian Stengaard-PetersenBent Deleuran

Published in: Rheumatology (Oxford, England) (2021)

In early RA, one single measurement of plasma CXCL13 at baseline, is superior to currently used clinical and serological disease markers, to predict longterm radiographic status and progression.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
systemic lupus erythematosus